Lyso-Gb1 Gaucher Disease Biomarker Interpreter

Interpret lyso-glucosylsphingosine (lyso-Gb1) plasma levels for Gaucher disease diagnosis, activity monitoring, and treatment response assessment using validated reference ranges and therapeutic targets.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Interpret lyso-glucosylsphingosine (lyso-Gb1) plasma levels for Gaucher disease diagnosis, activity monitoring, and treatment response assessment using validated reference ranges and therapeutic targets

Each component has a specific meaning:

  • Validated reference ranges — The validated reference ranges recorded for the scenario being assessed.
  • Therapeutic targets — The therapeutic targets recorded for the scenario being assessed.

Note: Interpret the lyso-gb1 monitor result against the thresholds and context described above.

How to Use

Enter the validated reference ranges, therapeutic targets for the scenario you are assessing. Interpret lyso-glucosylsphingosine (lyso-Gb1) plasma levels for Gaucher disease diagnosis, activity monitoring, and treatment response assessment using validated reference ranges and therapeutic targets. Use the lyso-gb1 monitor result to inform your calculation.

Frequently Asked Questions